Loading...
New Needle-Free Injection System: NuGen Medical Devices Inc. is developing a next-generation needle-free injection system that simplifies drug delivery and enhances patient safety, protected under international patent WO2021206553.
Innovative Design Features: The new system integrates a sterile internal insulin cartridge into the autoinjector, eliminating the need for external connectors and reducing risks of dosing errors and contamination.
Clinical Investigations and Prototypes: NuGen plans to begin clinical investigations using its current platform while developing prototypes within six months to showcase the technology and conduct usability studies.
Commitment to Patient Safety: Under CEO Liang Lin's leadership, NuGen aims to advance needle-free solutions that prioritize patient comfort and usability, with full tooling investment expected in early 2026 for scaled manufacturing.
